200 related articles for article (PubMed ID: 30209800)
21. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
22. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
Christ JP; Gunning MN; Fauser BCJM
Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
[TBL] [Abstract][Full Text] [Related]
23. Polycystic Ovarian Syndrome: A Primer.
Thornton EC; Von Wald T; Hansen K
S D Med; 2015 Jun; 68(6):257-61. PubMed ID: 26137726
[TBL] [Abstract][Full Text] [Related]
24. Polycystic Ovary Syndrome.
Meier RK
Nurs Clin North Am; 2018 Sep; 53(3):407-420. PubMed ID: 30100006
[TBL] [Abstract][Full Text] [Related]
25. PCOS phenotype focus: phenotype D under the magnifying glass.
Myers SH; Montanino Oliva M; Nordio M; Unfer V
Arch Gynecol Obstet; 2024 Jun; 309(6):2307-2313. PubMed ID: 38502188
[TBL] [Abstract][Full Text] [Related]
26. How polycystic ovary syndrome came into its own.
Azziz R
F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
[TBL] [Abstract][Full Text] [Related]
27. Evidence-based approach for the use of ultrasound in the management of polycystic ovary syndrome.
Nardo LG; Gelbaya TA
Minerva Ginecol; 2008 Feb; 60(1):83-9. PubMed ID: 18277355
[TBL] [Abstract][Full Text] [Related]
28. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
Merino P; Schulin-Zeuthen C; Codner E
Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
[TBL] [Abstract][Full Text] [Related]
29. PCOS diagnosis in adolescents: the timeline of a controversy in a systematic review.
Vassalou H; Sotiraki M; Michala L
J Pediatr Endocrinol Metab; 2019 Jun; 32(6):549-559. PubMed ID: 31141485
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of adolescent polycystic ovary syndrome.
Hardy TS; Norman RJ
Steroids; 2013 Aug; 78(8):751-4. PubMed ID: 23624032
[TBL] [Abstract][Full Text] [Related]
33. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
J Clin Endocrinol Metab; 2006 Nov; 91(11):4237-45. PubMed ID: 16940456
[TBL] [Abstract][Full Text] [Related]
34. Polycystic ovary syndrome in adolescents.
Rackow BW
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):281-7. PubMed ID: 22781076
[TBL] [Abstract][Full Text] [Related]
35. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
Hart R; Hickey M; Franks S
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
[TBL] [Abstract][Full Text] [Related]
36. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.
Sıklar Z; Berberoğlu M; Çamtosun E; Kocaay P
J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):78-83. PubMed ID: 25850587
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
[TBL] [Abstract][Full Text] [Related]
40. Application of a Standard Cross-Specialty Workup for Diagnosis and Metabolic Screening of Obese Adolescents With Polycystic Ovary Syndrome.
Huguelet PS; Olson E; Sass A; Bartz S; Hsu S; Cree-Green M
J Adolesc Health; 2021 Mar; 68(3):589-595. PubMed ID: 32819830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
